Antineoplastic and Apoptotic Potential of Traditional Medicines Thymoquinone and Diosgenin in Squamous Cell Carcinoma

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Das, Subhasis ^a   Dey, Kaushik Kumar ^a   Dey, Goutam ^a   Pal, Ipsita ^a   Majumder, Abhijit ^b   MaitiChoudhury, Sujata ^c   Kundu, Subhas C ^a   Mandal, Mahitosh ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c VIDYASAGAR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DIOSGENIN; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; THYMOQUINONE;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; SARCOMA 180; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TRADITIONAL MEDICINE; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOQUINONES; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL PROLIFERATION; DIOSGENIN; ELECTROPHORESIS, AGAR GEL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MEDICINE, TRADITIONAL; MICE; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION;

EID: 84867567251     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046641     Document Type: Article

References (37)

1. Johnson TM, Rowe DE, Nelson BR, Swanson NA, (1992) Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 26 (3 Pt 2): 467-484.
2. Salehi Z, Mashayekhi F, Shahosseini F, (2007) Significance of eIF4E expression in skin squamous cell carcinoma. Cell Biol Int 31 (11): 1400-1404.
3. Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N, Crooks PA, (2004) Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 15: 389-399.
4. Lei X, Lv X, Liu M, Yang Z, Ji M, et al. (2012) Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo. Biochem Biophysics Res Commun 417 (2): 864-868.
5. Woo CC, Loo SY, Gee V, Yap CW, Sethi G, et al. (2011) Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway. Biochem Pharmacol 82 (5): 464-475.
6. Roepke M, Diestel A, Bajbouj K, Walluscheck D, Schonfeld P, et al. (2007) Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol Ther 6: 160-169.
7. Kaseb AO, Chinnakannu K, Chen D, Sivanandam A, Tejwani S, et al. (2007) Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Cancer Res 67 (16): 7782-7788.
8. Gasparini G, Longo R, Toi M, Ferrara N, (2005) Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat Clin Pract Oncol 2: 562-577.
9. Kerr DJ, (2004) Targeting angiogenesis in cancer: clinical development of bevacizumab. Nat Clin Pract Oncol 1: 39-43.
10. El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, et al. (2010) Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 15 (2): 183-195.
11. McAnuff MA, Harding WW, Omoruyi FO, Jacobs H, Morrison EY, et al. (2005) Hypoglycemic effects of steroidal sapogenins isolated from Jamaican bitter yam, Dioscorea polygonoides. Food Chem Toxicol 43: 1667-1672.
12. Chen P-S, Shih Y-W, Huang H-C, Cheng H-W, (2011) Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinase expression. PLoS ONE 6 (5): e20164.
13. Li F, Fernandez PP, Rajendran P, Hui KM, Sethi G, (2010) Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway, leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett 292: 197-207.
14. Corbiere C, Liagre B, Terro F, Beneytout JL, (2004) Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res 14: 188-196.
15. Shishodia S, Aggarwal BB, (2006) Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene 25: 1463-1473.
16. Effenberger-Neidnicht K, Schobert R, (2011) Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemother Pharmacol 67 (4): 867-874.
17. Velho-Pereira R, Kumar A, Pandey BN, Jagtap AG, Mishra KP, (2011) Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis. Cell Biol Int 35 (10): 1025-1029.
18. Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, et al. (2010) ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. Cancer Biol Ther 9 (8): 592-603.
19. Venkatesan P, Puvvada N, Dash R, Prashanth Kumar BN, Sarkar D, et al. (2011) The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer. Biomaterials 32 (15): 3794-3806.
20. Mandal M, Olson DJ, Sharma T, Vadlamudi RK, Kumar R, (2001) Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 120 (1): 71-78.
21. Jaganathan SK, Mazumdar A, Mondhe D, Mandal M, (2011) Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int 35 (6): 607-615.
22. Chou TC, Talalay P, (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55.
23. Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, et al. (2011) ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells. J Cell Physiol 226 (2): 375-384.
24. Tornita K, Plager JE, (1979) In vivo cell cycle synchronization of the murine sarcoma 180 tumor following alternating periods of hydroxyurea blockade and release. Cancer Res 39: 4407-4411.
25. Ivankovic S, Stojkovic R, Jukic M, Milos M, Milos M, et al. (2006) The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo. Exp Oncol 28: 220-224.
26. Sethi G, Ahn KS, Aggarwal BB, (2008) Targeting NF-κB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res 6: 1059-1070.
27. Jafri SH, Glass J, Shi R, Zhang S, Prince M, et al. (2010) Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo. J Exp Clin Cancer Res 29: 87.
28. Al-Shabanah OA, Badary OA, Nagi MN, Al-Gharably NM, Al-Rikabi AC, et al. (1998) Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J Exp Clin Cancer Res 17: 193-198.
29. Badary OA, Taha RA, El-Din AMG, Abdel-Wahab MH, (2003) Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol 26: 87-98.
30. El-Mahdy MA, Zhu Q, Wang QE, Wani G, Wani AA, (2005) Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myoloblastic leukemia HL-60 cells. Int J Cancer 117: 409-417.
31. Chiang C-T, Way T-D, Tsai S-J, Lin J-K, (2007) Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation. FEBS Letters 581: 5735-5742.
32. Lee J, Jung K, Kim YS, Park D, (2007) Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling. Life Sci 81: 249-254.
33. Chien CS, Shen KH, Huang JS, Ko SC, Shih YW, (2010) Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells. Mol Cell Biochem 333: 169-180.
34. Van de Water B, Kruidering M, Nagelkerke JF, (1996) F-actin disorganization in apoptotic cell death of cultured rat renal proximal tubular cells. Am J Physiol 270: F593-F603.
35. Ito H, Shimura K, Itoh H, Kawade M, (1997) Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei (Iwade strain 101) "Himematsutake" and its mechanisms in tumor-bearing mice. Anticancer Res 17: 277-284.
36. Lee YL, Kim HJ, Lee MS, Kim JM, Han JS, et al. (2003) Oral administration of Agaricus blazei (H1 strain) inhibited tumor growth in a sarcoma 180 inoculation model. Exp Anim 52: 371-375.
37. Yang SX, Steinberg SM, Nguyen D, Wu TD, Modrusan Z, et al. (2008) Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer. Clin Cancer Res 14: 5893-5899.